Application Information

This drug has been submitted to the FDA under the reference 202388/001.

Names and composition

"SITAGLIPTIN; METFORMIN HYDROCHLORIDE" is the commercial name of a drug composed of SITAGLIPTIN and METFORMIN HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
202388/001 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 500MG
202388/002 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 1000MG
202426/001 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 500MG
202426/002 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 1000MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
202388/001 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 500MG
202388/002 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 1000MG
202426/001 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 500MG
202426/002 SITAGLIPTIN; METFORMIN HYDROCHLORIDE SITAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET/ ORAL 50MG and 1000MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved